323 related articles for article (PubMed ID: 28746872)
21. Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
Nellist M; van den Heuvel D; Schluep D; Exalto C; Goedbloed M; Maat-Kievit A; van Essen T; van Spaendonck-Zwarts K; Jansen F; Helderman P; Bartalini G; Vierimaa O; Penttinen M; van den Ende J; van den Ouweland A; Halley D
Eur J Hum Genet; 2009 Mar; 17(3):319-28. PubMed ID: 18830229
[TBL] [Abstract][Full Text] [Related]
22. The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex.
Tee AR; Sampson JR; Pal DK; Bateman JM
Semin Cell Dev Biol; 2016 Apr; 52():12-20. PubMed ID: 26849906
[TBL] [Abstract][Full Text] [Related]
23. Caloric restriction effects on liver mTOR signaling are time-of-day dependent.
Tulsian R; Velingkaar N; Kondratov R
Aging (Albany NY); 2018 Jul; 10(7):1640-1648. PubMed ID: 30018180
[TBL] [Abstract][Full Text] [Related]
24. Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis.
Bateup HS; Johnson CA; Denefrio CL; Saulnier JL; Kornacker K; Sabatini BL
Neuron; 2013 May; 78(3):510-22. PubMed ID: 23664616
[TBL] [Abstract][Full Text] [Related]
25. mTOR-related neuropathology in mutant tsc2 zebrafish: Phenotypic, transcriptomic and pharmacological analysis.
Scheldeman C; Mills JD; Siekierska A; Serra I; Copmans D; Iyer AM; Whalley BJ; Maes J; Jansen AC; Lagae L; Aronica E; de Witte PAM
Neurobiol Dis; 2017 Dec; 108():225-237. PubMed ID: 28888969
[TBL] [Abstract][Full Text] [Related]
26. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
Curatolo P
Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
[TBL] [Abstract][Full Text] [Related]
27. The Circadian Protein BMAL1 Regulates Translation in Response to S6K1-Mediated Phosphorylation.
Lipton JO; Yuan ED; Boyle LM; Ebrahimi-Fakhari D; Kwiatkowski E; Nathan A; Güttler T; Davis F; Asara JM; Sahin M
Cell; 2015 May; 161(5):1138-1151. PubMed ID: 25981667
[TBL] [Abstract][Full Text] [Related]
28. Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex.
Rensing N; Han L; Wong M
Epilepsia; 2015 Jul; 56(7):1088-97. PubMed ID: 26122303
[TBL] [Abstract][Full Text] [Related]
29. Timing of expression of the core clock gene Bmal1 influences its effects on aging and survival.
Yang G; Chen L; Grant GR; Paschos G; Song WL; Musiek ES; Lee V; McLoughlin SC; Grosser T; Cotsarelis G; FitzGerald GA
Sci Transl Med; 2016 Feb; 8(324):324ra16. PubMed ID: 26843191
[TBL] [Abstract][Full Text] [Related]
30. Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation.
Cao J; Tyburczy ME; Moss J; Darling TN; Widlund HR; Kwiatkowski DJ
J Clin Invest; 2017 Jan; 127(1):349-364. PubMed ID: 27918305
[TBL] [Abstract][Full Text] [Related]
31. Deubiquitinating enzyme USP9X regulates cellular clock function by modulating the ubiquitination and degradation of a core circadian protein BMAL1.
Zhang Y; Duan C; Yang J; Chen S; Liu Q; Zhou L; Huang Z; Xu Y; Xu G
Biochem J; 2018 Apr; 475(8):1507-1522. PubMed ID: 29626158
[TBL] [Abstract][Full Text] [Related]
32. Histone monoubiquitination by Clock-Bmal1 complex marks Per1 and Per2 genes for circadian feedback.
Tamayo AG; Duong HA; Robles MS; Mann M; Weitz CJ
Nat Struct Mol Biol; 2015 Oct; 22(10):759-66. PubMed ID: 26323038
[TBL] [Abstract][Full Text] [Related]
33. Seizure reduction in TSC2-mutant mouse model by an mTOR catalytic inhibitor.
Dhamne SC; Modi ME; Gray A; Bonazzi S; Craig L; Bainbridge E; Lalani L; Super CE; Schaeffer S; Capre K; Lubicka D; Liang G; Burdette D; McTighe SM; Gurnani S; Vermudez SAD; Curtis D; Wilson CJ; Hameed MQ; D'Amore A; Rotenberg A; Sahin M
Ann Clin Transl Neurol; 2023 Oct; 10(10):1790-1801. PubMed ID: 37545094
[TBL] [Abstract][Full Text] [Related]
34. d-Glucosamine induces circadian phase delay by promoting BMAL1 degradation through AMPK/mTOR pathway.
Li Z; Fu B; Wei A; Wu Y; Huang M; Zhang E; Cui B; Wang B; Peng H
Life Sci; 2023 Jul; 325():121765. PubMed ID: 37169147
[TBL] [Abstract][Full Text] [Related]
35. Microtubule Cytoskeletal Network Alterations in a Transgenic Model of Tuberous Sclerosis Complex: Relevance to Autism Spectrum Disorders.
Gąssowska-Dobrowolska M; Czapski GA; Cieślik M; Zajdel K; Frontczak-Baniewicz M; Babiec L; Adamczyk A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108467
[TBL] [Abstract][Full Text] [Related]
36. Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis.
McMahon J; Huang X; Yang J; Komatsu M; Yue Z; Qian J; Zhu X; Huang Y
J Neurosci; 2012 Nov; 32(45):15704-14. PubMed ID: 23136410
[TBL] [Abstract][Full Text] [Related]
37. Circadian and feeding rhythms differentially affect rhythmic mRNA transcription and translation in mouse liver.
Atger F; Gobet C; Marquis J; Martin E; Wang J; Weger B; Lefebvre G; Descombes P; Naef F; Gachon F
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6579-88. PubMed ID: 26554015
[TBL] [Abstract][Full Text] [Related]
38. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.
Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R
J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of circadian phenotypes utilizing fibroblasts from patients with circadian rhythm sleep disorders.
Hida A; Ohsawa Y; Kitamura S; Nakazaki K; Ayabe N; Motomura Y; Matsui K; Kobayashi M; Usui A; Inoue Y; Kusanagi H; Kamei Y; Mishima K
Transl Psychiatry; 2017 Apr; 7(4):e1106. PubMed ID: 28440811
[TBL] [Abstract][Full Text] [Related]
40. Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock.
Lee Y; Lee J; Kwon I; Nakajima Y; Ohmiya Y; Son GH; Lee KH; Kim K
J Cell Sci; 2010 Oct; 123(Pt 20):3547-57. PubMed ID: 20930143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
